Medifast Inc (MED) stock
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3057% below fair value
$12.20+0.01 (+0.08%)
Close on Nov 18, 2026Market cap $136.43MP/E –Yield 0.00%
Medifast operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Medifast's operating income for the twelve months ending Sep 30, 2026 was -$34.78M. For fiscal 2025 it was -$14.21M, down 593.8% from the year before. The highest annual figure on record is $216.24M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.21M | -593.8% |
| FY2024 | Dec 31, 2024 | $2.88M | -97.7% |
| FY2023 | Dec 31, 2023 | $126.40M | -31.6% |
| FY2022 | Dec 31, 2022 | $184.81M | -14.5% |
| FY2021 | Dec 31, 2021 | $216.24M | +61.2% |
| FY2020 | Dec 31, 2020 | $134.16M | +47.4% |
| FY2019 | Dec 31, 2019 | $91.04M | +31.8% |
| FY2018 | Dec 31, 2018 | $69.06M | +74.3% |
| FY2017 | Dec 31, 2017 | $39.63M | +47.6% |
| FY2016 | Dec 31, 2016 | $26.86M | -6.4% |
| FY2015 | Dec 31, 2015 | $28.68M | -5.2% |
| FY2014 | Dec 31, 2014 | $30.25M | -21.3% |
| FY2013 | Dec 31, 2013 | $38.41M | +41.5% |
| FY2012 | Dec 31, 2012 | $27.14M | -0.9% |
| FY2011 | Dec 31, 2011 | $27.38M | -13.5% |
| FY2010 | Dec 31, 2010 | $31.64M | +71.1% |
| FY2009 | Dec 31, 2009 | $18.50M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$19.36M | – |
| Q2 FY2026 | Jun 30, 2026 | -$4.33M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.30M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.80M | -1200.6% |
| Q3 FY2025 | Sep 30, 2025 | -$4.08M | -293.8% |
| Q2 FY2025 | Jun 30, 2025 | -$1.07M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.26M | -115.9% |
| Q4 FY2024 | Dec 31, 2024 | $709.00K | -91.8% |
| Q3 FY2024 | Sep 30, 2024 | $2.11M | -91.7% |
| Q2 FY2024 | Jun 30, 2024 | -$7.88M | -120.3% |
| Q1 FY2024 | Mar 31, 2024 | $7.94M | -85.2% |
| Q4 FY2023 | Dec 31, 2023 | $8.68M | -73.4% |
| Q3 FY2023 | Sep 30, 2023 | $25.51M | -47.0% |
| Q2 FY2023 | Jun 30, 2023 | $38.71M | -21.0% |
| Q1 FY2023 | Mar 31, 2023 | $53.51M | -2.9% |
| Q4 FY2022 | Dec 31, 2022 | $32.60M | -30.4% |
| Q3 FY2022 | Sep 30, 2022 | $48.16M | -12.7% |
| Q2 FY2022 | Jun 30, 2022 | $48.96M | -20.3% |
| Q1 FY2022 | Mar 31, 2022 | $55.09M | +4.3% |
| Q4 FY2021 | Dec 31, 2021 | $46.84M | +23.4% |
| Q3 FY2021 | Sep 30, 2021 | $55.17M | +23.8% |
| Q2 FY2021 | Jun 30, 2021 | $61.43M | +118.6% |
| Q1 FY2021 | Mar 31, 2021 | $52.80M | +124.4% |
| Q4 FY2020 | Dec 31, 2020 | $37.97M | +103.0% |
| Q3 FY2020 | Sep 30, 2020 | $44.56M | +119.9% |
| Q2 FY2020 | Jun 30, 2020 | $28.10M | +2.7% |
| Q1 FY2020 | Mar 31, 2020 | $23.53M | -4.8% |
| Q4 FY2019 | Dec 31, 2019 | $18.71M | -5.5% |
| Q3 FY2019 | Sep 30, 2019 | $20.26M | +16.0% |
| Q2 FY2019 | Jun 30, 2019 | $27.36M | +59.9% |
| Q1 FY2019 | Mar 31, 2019 | $24.72M | +68.3% |
| Q4 FY2018 | Dec 31, 2018 | $19.80M | +108.8% |
| Q3 FY2018 | Sep 30, 2018 | $17.47M | +70.8% |
| Q2 FY2018 | Jun 30, 2018 | $17.11M | +51.3% |
| Q1 FY2018 | Mar 31, 2018 | $14.68M | +70.6% |
| Q4 FY2017 | Dec 31, 2017 | $9.49M | +43.4% |
| Q3 FY2017 | Sep 30, 2017 | $10.23M | – |
| Q2 FY2017 | Jun 30, 2017 | $11.31M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.61M | – |
See a number that looks wrong?